longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Zentek

ZTEK

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -7.41, above the reasonable range, cheaper than 4.85% of the time in the past 3 years, and the industry ranks 36/45, the industry Median -0.27.

-7.41xP/E
--Stock price
-7.41xP/E
Stock price--

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-12.61x
Typical range
-14.51x–-10.51x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
017345168

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BLCOUSBausch + Lomb
-35.22x94.03%$6.02B
MMEDUSMiniMed
-17.90x146.72%$5.62B
NEOGUSNeogen
-379.80x316.68%$3.00B
ESTAUSEstablishment Labs
-50.55x30.16%$1.97B
XRAYUSDentsply Sirona
-3.43x113.34%$1.87B
KIDSUSOrthopediatrics
-14.82x27.74%$588.78M
CERSUSCerus
-77.84x56.25%$528.00M
SMTIUSSanara Medtech
-10.06x104.59%$322.13M
OSURUSOraSure Tech
-5.52x29.79%$271.05M
RXSTUSRxSight
-4.13x0.58%$193.82M
SKYAUSSkyAI
-0.20x--$81.31M
TELAUSTela Bio
-1.37x17.47%$56.57M
ZTEKFUSZENTEK LTD
-7.44x--$55.80M
XTNTUSXtant Med
-4.73x477.77%$52.71M
RMTIUSRockwell Medical
-6.44x32.67%$33.73M
NSPRUSInspireMD
-0.62x--$32.54M
RVPUSRetractable Tech
-5.82x--$20.95M
CUPRUSCuprina
-3.63x--$13.10M
LUCYUSInnovative Eyewear
-1.06x--$8.18M
AIDXUS20/20 Biolabs
-0.78x44.74%$5.55M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.